跳至主要内容
临床试验/NCT02438852
NCT02438852撤回3 期

Efficacy of Continuous Infusion of Local Anesthesia After Radical Cystectomy: A Randomized, Double Blind, Placebo Controlled Study

University of Southern California1 个研究点 分布在 1 个国家开始时间: 2019年2月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
试验地点
1
主要终点
Narcotic requirement

研究概览

简要总结

This randomized phase IV trial studies how well the continuous infusion of ropivacaine hydrochloride works in reducing pain after surgery in patients with bladder cancer. Ropivacaine hydrochloride is an anesthetic drug used to decrease pain by numbing an area of the body without putting the patient to sleep. Continuous infusion of ropivacaine hydrochloride may reduce pain and improve the quality of life for patients after bladder surgery.

详细描述

PRIMARY OBJECTIVES:

I. To determine if continuous infusion of local anesthesia (CILA) decreases post-operative pain after radical cystectomy (RC).

II. To determine if CILA reduces narcotic requirements after RC.

SECONDARY OBJECTIVES:

I. To determine if CILA decreases length-of-stay after RC. II. To determine if CILA improves patients satisfaction with post-operative pain control after RC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing elective open radical cystectomy
  • Ability to understand and the willingness to sign a written informed consent

排除标准

  • Allergy or adverse reaction to ropivacaine (ropivacaine hydrochloride) or any amide type of local anesthesia
  • Allergy or adverse reaction to local anesthesia catheter
  • Additional surgery at the same time as RC (e.g. nephroureterectomy)
  • Coagulopathy
  • Thrombocytopenia
  • Local or systemic infection
  • Pregnancy
  • Chronic hepatic disease
  • Use of type III antiarrhythmics (e.g. amiodarone)
  • History of chronic pain and/or daily opioid use

研究组 & 干预措施

Arm I (ropivacaine hydrochloride)

Experimental

Patients receive ropivacaine hydrochloride IV continuously over 72 hours after radical cystectomy.

干预措施: Questionnaire Administration (Other)

Arm I (ropivacaine hydrochloride)

Experimental

Patients receive ropivacaine hydrochloride IV continuously over 72 hours after radical cystectomy.

干预措施: Ropivacaine Hydrochloride (Drug)

Arm II (placebo)

Placebo Comparator

Patients receive normal saline (placebo) IV continuously over 72 hours after radical cystectomy.

干预措施: Placebo (Other)

Arm II (placebo)

Placebo Comparator

Patients receive normal saline (placebo) IV continuously over 72 hours after radical cystectomy.

干预措施: Questionnaire Administration (Other)

结局指标

主要结局

Narcotic requirement

时间窗: Up to 72 hours after surgery

Total narcotic dose after surgery until 72 hours will be analyzed as continuous variables and will be compared with the one sided t-test in an intention-to-treat manner.

次要结局

  • Length of hospitalization(Up to 30 days after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Continuous Infusion of Ropivacaine Hydrochloride in... | 临床试验